| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |